文献速递胸部神经PETCT

18F-FDG PET/CT影像组学预测I-IIIA期术后非小细胞肺癌脑转移

18F-FDG PET/CT radiomics predicts brain metastasis in I-IIIA resected Non-Small cell lung cancer.
PubMed 文献 · Eur J Radiol · 2023-06-20

本研究纳入两家机构203例接受手术的非小细胞肺癌患者,基于18F-FDG PET/CT影像组学特征联合临床病理因素建立脑转移预测模型。PET/CT影像组学模型在训练、内部验证和外部验证队列的C指数分别为0.911、0.825和0.800,联合模型分别为0.927、0.861和0.860。决策曲线分析提示PET/CT列线图具有临床获益。

要点

  • PET/CT影像组学模型在外部验证队列预测术后脑转移的C指数为0.800。
  • 联合影像组学与临床病理特征的模型预测性能更优,外部验证C指数为0.860。
  • 神经元特异性烯醇化酶(NSE)和空气支气管征是脑转移的独立危险因素。

核心结论

  • 基于PET/CT影像信息与临床病理特征构建的预测算法可能准确预测非小细胞肺癌患者术后脑转移概率,为筛查高危患者提供了新方法。

研究设计与样本

  • 研究纳入两家机构203例接受手术治疗的非小细胞肺癌患者,分析代谢指标、CT特征和临床特征以识别脑转移独立预测因素,并建立整合影像组学特征与临床病理危险变量的预测模型,从区分度、校准度和临床适用性评估模型性能。

关键影像表现/征象

  • 空气支气管征是脑转移的独立危险因素。
  • 神经元特异性烯醇化酶(NSE)是脑转移的独立危险因素。

诊断标准与关键数值

  • PET/CT影像组学模型在训练队列的C指数为0.911,内部验证队列为0.825,外部验证队列为0.800。
  • 联合模型在训练队列的C指数为0.927,内部验证队列为0.861,外部验证队列为0.860。
  • 决策曲线分析提示PET/CT列线图具有临床获益。

临床应用与阅片要点

  • 作者认为基于PET/CT影像信息与临床病理特征的预测算法可能准确预测非小细胞肺癌患者术后脑转移概率。
  • 作者认为该算法为筛查非小细胞肺癌术后脑转移高危患者提供了独特技术手段。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To establish 18F-FDG PET/CT radiomics model for predicting brain metastasis in non-small cell lung cancer (NSCLC) patients.

METHODS: This research comprised 203 NSCLC patients who had received surgical therapy at two institutions. To identify independent predictive factors of brain metastasis, metabolic indicators, CT features, and clinical features were investigated. A prediction model was established by incorporating radiomics signature and clinicopathological risk variables. The suggested model's performance was assessed from the perspective of discrimination, calibration, and clinical application.

RESULTS: The C-indices of the PET/CT radiomics model in the training, internal validation, and external validation cohorts were 0.911, 0.825 and 0.800, respectively. According to the multivariate analysis, neuron-specific enolase (NSE) and air bronchogram were independent risk factors for brain metastasis (BM). Furthermore, the combined model integrating radiomics and clinicopathological characteristics related to brain metastasis performed better in terms of prediction, with C-indices of 0.927, 0.861, and 0.860 in the training, internal validation, and external validation cohorts, respectively. The decision curve analysis (DCA) suggested that the PET/CT nomogram was clinically beneficial.

CONCLUSIONS: A predictive algorithm based on PET/CT imaging information and clinicopathological features may accurately predict the probability of brain metastasis in NSCLC patients following surgery. This presented doctors with a unique technique for screening NSCLC patients at high risk of brain metastasis.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Zheng, Wang, Tan, et al. 18F-FDG PET/CT radiomics predicts brain metastasis in I-IIIA resected Non-Small cell lung cancer. Eur J Radiol. 2023. PMID: 37406583. doi:10.1016/j.ejrad.2023.110933

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。